Evaluating the Use of Oseltamivir for the Treatment of Influenza in Adults
Status:
Completed
Trial end date:
2017-11-18
Target enrollment:
Participant gender:
Summary
People who are infected with the influenza virus may develop respiratory illnesses, such as
pneumonia, or other life-threatening complications. Currently, there are four antiviral
medications that are used to treat influenza. This study will examine one of these
medications, oseltamivir, to examine how it affects the shedding of influenza virus in
infected people.
Phase:
N/A
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)